James R. Berenson

February 8, 2022

0 Comments

Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study

On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest findings and … Article

Continue reading...
Emory Universitys Big Discovery

February 7, 2022

0 Comments

IMBCR & Emory University’s Big Discovery!!!

Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against SARS-CoV-2 is unknown. Thus, … Article

Continue reading...
Berenson Cancer Center

February 6, 2022

0 Comments

James R. Berenson, MD, Inc. Announces Rebranding and Changes Organization Name to Berenson Cancer Center

New name, logo, and business unit alignment introduced as part of an extensive rebranding initiative

LOS ANGELES, Nov. 11, Article

Continue reading...